1. Normal leucocyte lysosome-rich granular fractions exhibited counter-transport of cystine, confirming that cystine transport across the lysosomal membrane is carrier-mediated. 2. The trans-activation of cystine transport was temperature-dependent but relatively independent of the external Na+ or K+ concentration in phosphate buffer. 3. Counter-transport, measured as uptake of exogenous [3Hlcystine, increased with increasing intralysosomal cystine content up to approx. 3nmol of half-cystine/unit of hexosaminidase activity. 4. The amount of PHlcystine entering lysosomes loaded with unlabelled cystine decreased when unlabelled cystine was added to the extralysosomal medium. 5. Lysosomal cystine counter-transport was stereospecific for the L-isomer. Cystathionine, cystamine and cysteamine-cysteine mixed disulphide gave evidence of sharing the lysosomal cystine-transport system, although at lower activity than cystine. Other tested amino acids, including arginine, glutamate and homocystine, were inactive in this system. 6. Nine leucocyte lysosome-rich preparations from eight different cystinotic patients displayed virtually no counter-transport of cystine, conclusively establishing that a carrier-mediated system for cystine transport is dysfunctional in cystinotic lysosomes.
Exposure of rat liver (Goldman & Kaplan, 1973; Reeves, 1979) or human leucocyte (Steinherz et al., 1982a ) granular fractions to certain amino acid methyl esters results in intralysosomal ester hydrolysis and accumulation of the corresponding free amino acid. This method was used to measure cystine egress from intact human leucocytes (Steinherz et al., 1982b) and from isolated lysosomal-rich granular fractions . The exodus of cystine from the isolated lysosomal preparations was matched by the appearance of cystine in the supernatant after the granular fractions had been centrifuged (Gahl et 1982a). In normal leucocyte lysosomes, the velocity of cystine egress was unaltered by 1 mM-N-ethylmaleimide and reached a maximum rate as cystine loading of the lysosomes increased, suggesting a saturable transport system (Gahl et al., 1982b) .
The same studies were performed in leucocytes from patients with cystinosis, a lysosomal storage disease in which free cystine accumulates within lysosomes of various cells (Schneider & Schulman, 1982; Schulman, 1973) . There was negligible egress of cystine from whole leucocytes (Steinherz et al., 1982b) or from isolated cystinotic lysosomes , suggesting that a cystine-transport system normally present in lysosomal membranes is defective in cystinosis.
The above studies were of special interest because previously there was no experimental support for the concept that lysosomal amino acid transport might, in some cases, be carrier-mediated. Indeed, it Vol. 216 appeared that egress of certain amino acids other than cystine from lysosomes might be diffusional (Reeves. 1979 : Steinherz et al., 1982a . Furthermore. our own studies of lysosomal cystine egress, which demonstrated saturation kinetics (Gahl et al., 1982b) , were of necessity accomplished at lysosomal cystine loadings that probably approximate the physical solubility of this compound at intralysosomal pH. Therefore we attempted to determine whether lysosomal cystine transport is accompanied by counter-transport, which constitutes classical evidence for a carrier-mediated (as opposed to diffusional) system of transmembrane movement (Wilbrandt & Rosenberg, 1961) . In counter-transport. tracer amounts of a radiolabelled substance will cross a membrane at an increased rate if there is a substantial concentration of the non-radioactive substance on the opposite side of the membrane.
We now report that normal lysosomal cystine transport exhibits trans-activation and that there is little or no counter-transport of cystine across cystinotic lysosomal membranes. We also describe the properties of normal counter-transport of Lcystine with respect to saturability, temperature, by reaction of L-cystine disulphoxide (Emiliozzi & Pichat, 1959) with the appropriate thiols under the conditions described by Eriksson & Eriksson (1967) for the preparation of cysteine-glutathione mixed disulphide. The filtered reaction mixtures were applied to the top of a Dowex 1 (formate form) column, and the components were separated with a formic acid gradient (Eriksson & Eriksson, 1967 (Steinherz et al., 1982b; Gahl et al., 1982a) . Control cells were not exposed to the methyl ester. After washing and sonication of the cells at 4°C in 10 mM-Hepes [4-(2-hydroxyethyl)-l-piperazineethanesulphonic acidl/NaOH buffer, pH 7.0, containing 0.25 M-sucrose, a post-nuclear granular fraction was prepared by centrifugation at 8500g for 10min. This was resuspended in cold 0.25 M-sucrose containing 1 mM-N-ethylmaleimide (Pierce Chemical Co.) and either 10mM-Hepes/NaOH buffer, pH 7.0, or 10mM-sodium phosphate buffer, pH 6.0, and incubated at 37°C in the presence of 8,uM-[3Hlcystine. At zero and later times, samples were removed and centrifuged at 17000g for 10min. The supernatant was assayed for soluble hexosaminidase activity, which averaged approx. 8% of total hexosaminidase at zero time and approx. 16% of total after 60 min at 37°C. The pellet was washed twice with 2ml of buffered sucrose, once by resuspension with a Pasteur pipette and once by resuspension with a glass pestle, with subsequent centrifugation. Final hexosaminidase recovery in the pellet approximated 63% of initial activity. The final pellet was taken up in 1 ml of buffered sucrose plus 10,l of 4% (v/v) Triton X-100. The radioactivities of duplicate 100,u1 portions were counted in a Beckman scintillation counter and assayed for hexosaminidase activity with 4-methylumbelliferyl 2-acetamido-2-deoxyf,-D-glucopyranoside (1.2 mM) (Koch-Light Laboratories) in citrate buffer as previously described (Gahl et al., 1982b) . 13HlCystine entrance was expressed as c.p.m./unit of hexosaminidase at the designated time minus the zero-time value. The radioactivity value was converted into pmol of cystine by dividing by the c.p.m./pmol of the 13Hlcystine in the incubation medium ( Fig. 5 ).
High-voltage electrophoresis was employed to verify that [3Hlcystine had entered as cystine (Steinherz et al., 1982a; Gahl et al., 1982a) and that [1"SIcystathionine had entered as cystathionine (Table 1) . To assess loading with unlabelled cystine, the cystine-binding-protein assay method of Oshima et al. (1974) was used.
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Results
A normal leucocyte granular fraction was loaded with unlabelled cystine to concentrations saturating with respect to cystine egress (Gahl et al., 1982b) and then exposed to tracer quantities of radioactive cvstine. PHlCystine entrance increased approximately linearly with time of incubation until at least 60min and plateaued by approx. 120min at 37°C (Fig. 1) . The 3H label that entered was identified as 1 3HIcystine by high-voltage electrophoresis of granular-fraction acid extracts (Steinherz et al., 1982a; Gahl et al., 1982b) . Uptake was reversible; if a cystine-loaded granular fraction was exposed to 1 3Hlcystine for 2h. washed thoroughly at 4°C, resuspended in sucrose/Hepes buffer, pH7.0, containing 1 mM-N-ethylmaleimide, and then kept at 37°C for 1 h, radioactivity re-accumulated outside the lysosomes at a substantial rate not accounted for by lysosomal rupture (results not shown). Granular fractions not loaded with cystine showed virtually no [3HIcystine uptake ( Fig. 1 ).
In control experiments, granular fractions from leucocytes exposed to 0.25mM-tryptophan methyl ester took up negligible P3HI, as did cystine-loaded Human leucocytes were exposed to either no (0) or 1 mM (0) unlabelled cystine dimethyl ester, and granular fractions were placed in 0.25 M-sucrose/ 1 mM-N-ethylmaleimide/ 10 mM-Hepes/NaOH buffer, pH 7.0. containing 7.2puM-I3Hlcystine (1.1 Ci/ mmol) at 37°C. Samples of granular fraction were removed at different times, washed, assayed for total hexosaminidase activity and their radioactivities counted as described in the text. Table 1 . Uptake of radioactive compounds bv normal leucocvte granularfractions loaded with unlabelled cvstine Normal leucocytes were exposed to no or 1 mM-cystine dimethyl ester for 30min at 37°C. Granular fractions were prepared and placed in 0.25M-sucrose/ImM-N-ethylmaleimide in either 10mM-sodium phosphate buffer, pH6.0 (Expt. 1) or 10mM-Hepes/NaOH buffer, pH7.0 (Expts. II and III), plus the radioactive compound diluted with unlabelled chemical to achieve the listed concentration. Entrance of label after I h at 370C was determined as described in the Experimental section and the value was converted into pmol by dividing the compound's specific radioactivity. Mean soluble hexosaminidase activity at zero time (6.7% for non-cystine-loaded lysosomes; 10.0% for cystine-loaded lysosomes) and at h (13.3% for non-cystine-loaded lysosomes; 17.8% for cystine-loaded lysosomes) was not increased in the presence of any of the added compounds. Expt. I: loaded granular fractions contained 6.4nmol of half-cystine/unit of hexosaminidase activity. All 3H-labelled compounds were adjusted to 876mCi/mmol; ["4Clalanine specific radioactivity was 87.6mCi/mmol; ['4C]glutamate specific radioactivity was 280 mCi/mmol. Expt. II: loaded granular fractions contained 4.4 nmol of half-cystine/unit of hexosaminidase activity.
The 3H-labelled compounds were adjusted to a specific radioactivity of 876 mCi/mmol. Expt. III: loaded granular fractions contained 6.5nmol of half-cystine/unit of hexosaminidase activity. [35SlCystine, [35Slhomocystine and 135S lcystathionine were adjusted to approx. 6.5, 13.1 and 8.3 mCi/mmol respectively. Lysosomal uptake (pmol/unit of hexosaminidase per h) (Table 1) .
For cystine-loaded lysosomes exposed to PH1-cystine for 1 h, uptake of radioactivity/unit of hexosaminidase was constant over a range of 0.6-13.7 units of hexosaminidase per 1 ml sample. In most experiments reported in the present paper the samples contained lysosomes with 1-5 units of hexosaminidase activity. Background or non-specific binding of 1 3Hicystine to granular fractions was diminished considerably by including 1 mM-N-ethylmaleimide in the external medium. Cystine counter-transport was temperaturedependent ( Fig. 2) , with a Ql0 of approx. 2.0. The estimated energy of activation was 47.7kJ/mol (1 1.4 kcal/mol). Normal cystine counter-transport was similar in phosphate buffer at pH 6.0 and Hepes buffer at pH 7.0. Subsequent experiments were performed in 0.25 M-sucrose/I mM-N-ethylmaleimide in either 10mM-sodium phosphate buffer, pH6.0, or 10mM-Hepes/NaOH buffer, pH7.0. 13HiCystine countertransport was relatively independent of the KCI or NaCl concentration in the phosphate buffer (Fig. 3) .
The rate of 1 3Hicystine uptake increased with increasing amounts of intralysosomal cystine loading, then tended to level off (Fig. 4) . Because the greatest rate of counter-transport was achieved at loadings above 3nmol of half-cystine/unit of hexosaminidase, such loadings were used to generate the data in all the other Figures.
As the final concentration of extralysosomal L-cystine, with tracer 13H]cystine, was progressively increased, total cystine uptake by the loaded normal granular fractions increased with a gradually decreasing slope (Fig. 5) . Supporting data are also found in Table 2 . The highest extralysosomal L-cystine concentration that could be tested was limited by the solubility of cystine at pH 6.0. A crude estimate of maximum uptake of L-cystine would be approx. 600 pmol of half-cystine/unit of hexosaminidase per h, not very different from the maximum observed exodus rate of 15 pmol of Normal leucocytes were exposed to 0-2.0mM-cystine dimethyl ester, and their respective granular fractions were incubated at 3 7 0 C in 0.25 M-sucrose/ 1 mM-N-ethylmaleimide/1lOmM-sodium phosphate buffer, pH 6.0, containing 7.5 pM-I 3H ]cystine (876mCi/mmol). Uptake of radioactivity per hexosaminidase unit was determined after 1 h. * and U symbols represent different experiments. Cystinotic leucocytes from eight different patients (0) were exposed to I mM-cystine dimethyl ester and their granular fractions were incubated at 370C for 1 h in 0.25 M-sucrose / 1 mM-N-ethylmaleimide containing 5.2-7.6 pM-l 3Hlcystine (876-1100 mCi/mmol) in lOmM-Hepes/NaOH buffer. pH7.0. 25mM-sodium phosphate buffer, pH6.0. or 10mM-sodium phosphate buffer. pH6.0. Most cystinotic leucocytes were obtained 5 h after an oral dose of cysteamine (approx. l5mg/kg): patient A was receiving cysteamine at a lower dosage and patient B had received no cysteamine for 24h. suggesting competition between radioactive and non-radioactive cystine for a limited number of transport carrier molecules.
half-cystine/unit of hexosaminidase per min previously reported (Gahl et The technique of cystine counter-transport was used to determine which compounds share the cystine-transport system with cystine. Two approaches were employed: non-radioactive compounds were tested for competition with tracer [3HIcystine for entrance into cystine-loaded lysosomes (Table 2) . and radioactive compounds were examined for direct entrance into cystineloaded lysosomes (Table 1 ). In the former studies, it was first shown that non-radioactive extralysosomal cystine at 0.08-0.86mm did decrease the amount of tracer P3Hlcystine entering normal cystine-loaded lysosomes (Table 2 ). In fact, an approximate Km of 0.5mm can be calculated for the cystine-transport system. D-Cystine at 0.86 mm, as well as at lower concentrations. did not compete with I3Hlcystine for counter-transport. Nor was their substantial competition with any of several 4.4mM-L-amino acids, including the dibasic amino acid arginine, or with 1.8mM-L-homocystine. L-Cystathionine and S-ethylcysteine. at 1.8mM. decreased entrance of radioactive cystine by 31% and 18% respectively, and DL-homocysteic acid, JB-carboxyethylthiocysteine, S-methylcysteine, the N-ethylmaleimide adduct of cysteine and D-penicillamine-L-cysteine disulphide did not substantially affect 3H Icystine countertransport. The D-penicillamine disulphide at I mM caused excessive lysosomal rupture and could not be tested. At 1.6 mm cystamine decreased 3H Icystine entrance by 56%; this could not be attributed to contamination with cystine, which was measured at less than 0.05%/o of the cystamine concentration. Cysteamine-cysteine disulphide, at approx. 1.8 mm, inhibited cystine counter-transport by 45%; measured contamination of this disulphide with cystine (0.1-Vol. 216 (Steinherz et al., 1982a; Gahl et al., (1.8mM) ( Steinherz et al., 1982b) or their isolated lysosomes : Determined by amino acid analyser; contained (Gahl et al., 1982a,b) . 6-10% (molar ratio) of cystine.
Discussion § Contained less than 0.01% of L-cystine by assay with cystine-binding protein and less than 0.05% of
The demonstration of a lysosomal transport cystine by amino acid analyser.
system for cystine provides new insights as to the 1983 mechanisms by which certain small molecules, produced in part through enzymic catabolism of macromolecules, may escape from the intralysosomal space. The first for which evidence indicates a lysosomal carrier, cystine, has Mr 240, which may be expected to impair it from crossing the lysosomal membrane at an appreciable rate by simple diffusion (Schulman, 1973; Goldman, 1973) . Cystine egress from normal and cystinotic human lysosomes could be studied by our modification of a loading technique developed by Goldman & Kaplan (1973) and by Reeves (1979) for the study of rat liver lysosomes. Goldman & Kaplan (1973) found that the methyl esters of certain amino acids were hydrolysed inside isolated lysosomes to yield high concentrations of free amino acids. Reeves (1979) exploited this phenomenon to study the egress of certain radioactive amino acids (but not cystine) from rat liver lysosomes, and showed that nonlysosomal contamination did not interfere with the results. In our laboratory, this technique was extended to isolated human leucocyte granular fractions, and cystine was shown to be among the amino acids for which loading of lysosomes could be achieved by the methyl ester method (Steinherz et al., 1982a) . We subsequently observed that the methyl ester method could be used to load normal and cystinotic lysosomes within whole leucocytes with cystine (Steinherz et al., 1982b) , and that there was a measurable rate of cystine egress from normal, but not from cystinotic, human lysosomes isolated from such cystine-loaded leucocytes . Supporting evidence has been reported by others (Jonas et al., 1982) . When velocity of normal cystine egress was plotted against the initial intralysosomal cystine loading, the saturability of the normal lysosomal cystine-transport system was suggested (Gahl et al., 1982b) .
Demonstration of saturability provided evidence that normal lysosomal cystine transport was carriermediated. However, the utility of any 'egress' system for studying transport was limited by the restricted ability to alter and measure conditions inside the intact lysosomes. For example, we know of no way to load normal lysosomes simultaneously with predictable concentrations of both cystine and another compound, which would be required to test such compounds in an egress system for competition with cystine via a putative carrier. In addition, the egress system measures cystine movement only down its concentration gradient, and studies carrier binding only under conditions of cystine excess, and unbinding in dilute (external) cystine solutions.
The counter-transport system, on the other hand, permits precise modification of the extralysosomal environment, and detailed study of various aspects of cystine transport. For example, counter-transport measurement has allowed straightforward demonstration of what compounds compete with cystine for its carrier. Furthermore, in contrast with egress, counter-transport is not substantially influenced by unlabelled cystine leaking from loaded lysosomes, because at the low extralysosomal [3Hlcystine concentration used entrance is a linear function of extralysosomal cystine concentration and dilution with unlabelled cystine does not alter the total radioactivity taken up. Counter-transport also effectively measures cystine transport at very dilute cystine concentrations.
The counter-transport systems shows unambiguously that cystine movement across normal lysosomal membranes is carrier-mediated (Fig. 1) , of roughly equal magnitude in both directions (Gahl et al., 1982b) (Fig. 5 and the Results section), and defective in cystinosis (Gahl et al., 1982a,b) (Fig. 4) .
[In addition, the counter-transport technique may assist in diagnosing heterozygotes for cystinosis (W. A. Gahl (Fig. 3) . It has also shown that the carrier is stereospecific for L-cystine and does not accept certain other amino acids for transport (Table 1) , notably arginine, which shares with cystine a renal tubular-cell and intestinal-cell plasma-membrane transport system in humans (Dent & Rose, 1951) , nor L-glutamate, whose transport into human fibroblasts is shared with cystine (Bannai & Kitamura, 1980) . On the other hand, cystathionine, cystamine and the cysteamine-cysteine disulphide each gave evidence of competition with or actual transport by the cystine carrier (Tables 1 and 2 ). It should be noted that L-cystine was a far better competitor against 13Hlcystine uptake than was any other compound tested, and that the sharing of the cystine-transport system by the cysteamine-cysteine disulphide in no way eliminates the possibility that the mixed disulphide may also exit from lysosomes by another means, e.g. simple diffusion. This concept is central to a working hypothesis on the mechanism of cystine depletion by cysteamine in cystinosis (Thoene et al., 1976) .
Lysosomes provide various degradatory functions. Some of the resulting products are molecules that may not readily diffuse out of the lysosomes, and for these compounds lysosomal membrane transport systems may normally exist. For example, Docherty et al. (1979) , using the osmotic-protection method, offered evidence for carrier-mediated sugar transport across rat liver lysosome membranes. Therefore the cystine carrier is likely to be only the first of such transport systems to be identified in man. The elucidation of other transport systems may be aided by studying counter-transport of small molecules in the normal state and in diseases with Vol. 216 lysosomal storage of small-M, compounds. One may speculate, for example, that certain forms of freesialic acid-storage diseases (Horwitz et al., 1981) or certain defects in vitamin-B12 metabolism causing combined methylmalonicacidaemia and homocystinaemia (Mudd & Levy, 1978) could result from defective lysosomal transmembrane transport.
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